Schedule of Conference Call for Investors and analysts
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited) has scheduled an earnings conference call for investors and analysts on Tuesday, May 12, 2026 at 6:30 PM IST. The call will discuss the company's Q4 and FY26 audited financial results, which are planned to be released earlier that same day. Senior management will open with a brief discussion on the results followed by an interactive Q&A session. The company has provided multiple dial-in numbers including Indian, Singapore, Hong Kong, US, and UK toll-free numbers, with pre-registration available for participants. Investor relations contact is Cyndrella Carvalho, Head – Investor Relations.
This is a routine earnings-related disclosure. The call follows the scheduled release of Q4 & FY26 results, giving investors and analysts an early opportunity to hear management's perspective and ask questions. The filing has no direct share price impact but is a standard IR practice for listed companies.